WeVote
Log In

Bill

Bill

SB 2725

TANF funds; prohibit providing to any person whose income is more than 200% of poverty level.

2025 Regular Session Introduced by Rod Hickman

The bill bans bottling or selling hemp cannabinoids in any caffeinated package, including ready-to-drink beverages, defining eligible cannabinoids and intoxicating effects by rule.

Died In Committee
#appropriations #publichealthandwelfare
0
WeVote Research Nonpartisan
Bill Summary · SB 2725

Summary — SB 2725 (2025) — Amendment to the Industrial Hemp Act (Caffeine + Hemp Cannabinoids)

Note on bill identity: The bill metadata provided included an unrelated title about TANF funds. The statutory text and sponsor information below show SB 2725, introduced by Sen. Julie A. Morrison, amends the Illinois Industrial Hemp Act (505 ILCS 89/20) to restrict sale of hemp cannabinoid products in caffeinated bottled/packaged beverages. This summary reflects the bill text as introduced.

Purpose

To prohibit the bottling and retail sale of hemp cannabinoid products in any package or container that contains caffeine — expressly including ready-to-drink beverages — and to define which cannabinoids are covered.

Key provisions

  • Amends Section 20 of the Industrial Hemp Act (505 ILCS 89/20).
  • Preserves current legality: subsection (a) states the Act does not change the legality of hemp or hemp products currently legal to possess or own.
  • New prohibition (subsection (b)): “No hemp cannabinoid shall be bottled and sold for purchase in a package or container that contains caffeine,” with explicit inclusion of ready-to-drink beverages.
  • Defines “hemp cannabinoid” as a naturally occurring phytocannabinoid derived from hemp that does not have an intoxicating effect (to be determined by the Department by rule). The bill lists examples:
    1. cannabidiol (CBD)
    2. cannabichromene (CBC)
    3. cannabicitran (CBT)
    4. cannabicyclol (CBL)
    5. cannabielsoin (CBE)
    6. cannabigerol (CBG)
    7. cannabidivarin (CBDV)
    8. cannabinol (CBN)

Who would be affected

  • Manufacturers, packagers, and distributors of hemp-derived cannabinoid products, particularly those producing bottled or otherwise packaged beverages that contain both hemp cannabinoids and caffeine.
  • Retailers selling ready-to-drink or bottled beverages containing hemp cannabinoids.
  • Consumers who purchase caffeinated CBD/hemp cannabinoid beverages.
  • State regulators (the referenced “Department”) responsible for defining “intoxicating effect” by rule and enforcing the prohibition.

Procedural status & timeline (as provided)

  • Filed/Received by Secretary of the Senate: March 13, 2025 (and additional filing entries noted Oct 28, 2025).
  • First reading / referred to committees (various entries list Transportation; Assignments; Public Health and Welfare; Appropriations).
  • Legislative action: Died in Committee (listed 2025-02-04).
  • Sponsor: Sen. Julie A. Morrison.
  • Related/companion bill: HB 5253.

Notes / Implementation and impact

  • The bill does not specify penalties or enforcement mechanisms beyond existing authorities under the Industrial Hemp Act; enforcement details would rely on existing statutory provisions and Department rulemaking.
  • Prohibiting caffeinated hemp cannabinoid beverages could materially affect an emerging market segment (CBD + energy/soft drinks) — producers might need to reformulate products or discontinue certain SKUs for sale in Illinois.
  • The Department is tasked with defining “intoxicating effect” by rule for purposes of identifying covered cannabinoids.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.